Reduced Effectiveness of Interruptive Drug-Drug Interaction Alerts after Conversion to a Commercial Electronic Health Record
- 430 Downloads
Drug-drug interaction (DDI) alerts in electronic health records (EHRs) can help prevent adverse drug events, but such alerts are frequently overridden, raising concerns about their clinical usefulness and contribution to alert fatigue.
To study the effect of conversion to a commercial EHR on DDI alert and acceptance rates.
Two before-and-after studies.
3277 clinicians who received a DDI alert in the outpatient setting.
Introduction of a new, commercial EHR and subsequent adjustment of DDI alerting criteria.
Alert burden and proportion of alerts accepted.
Overall interruptive DDI alert burden increased by a factor of 6 from the legacy EHR to the commercial EHR. The acceptance rate for the most severe alerts fell from 100 to 8.4%, and from 29.3 to 7.5% for medium severity alerts (P < 0.001). After disabling the least severe alerts, total DDI alert burden fell by 50.5%, and acceptance of Tier 1 alerts rose from 9.1 to 12.7% (P < 0.01).
Changing from a highly tailored DDI alerting system to a more general one as part of an EHR conversion decreased acceptance of DDI alerts and increased alert burden on users. The decrease in acceptance rates cannot be fully explained by differences in the clinical knowledge base, nor can it be fully explained by alert fatigue associated with increased alert burden. Instead, workflow factors probably predominate, including timing of alerts in the prescribing process, lack of differentiation of more and less severe alerts, and features of how users interact with alerts.
KEY WORDSclinical decision support adverse drug events drug-drug interactions electronic health records safety
None other than the authors as listed.
Research reported in this publication was supported by the National Library of Medicine (NLM) of the National Institutes of Health under Award Number R01LM011966 and the Agency for Healthcare Research and Quality (AHRQ) Center for Education and Research on Therapeutics grant 1U18HS016970. The content is solely the responsibility of the authors and does not necessarily represent the official views of NIH or AHRQ. Neither NIH nor AHRQ were involved in the design or execution of the project or the decision to publish the results.
Compliance with Ethical Standards
Approval for the study was obtained from the Partners HealthCare Institutional Review Board.
Early data from this study was presented as a poster at the 2016 AMIA Annual Symposium.
Conflict of Interest
The authors declare that they do not have a conflict of interest.
- 10.Dumbreck S, Flynn A, Nairn M, et al. Drug-disease and drug-drug interactions: systematic examination of recommendations in 12 UK national clinical guidelines. BMJ; 2015.Google Scholar
- 11.Wright A, Hickman TT, McEvoy D, et al. Analysis of clinical decision support system malfunctions: a case series and survey. Journal of the American Medical Informatics Association : JAMIA. 2016.Google Scholar
- 13.Kuperman GJ, Bates DW, Teich JM, Schneider JR, Cheiman D. A new knowledge structure for drug-drug interactions. Proceedings. Symposium on Computer Applications in Medical Care. 1994:836–40.Google Scholar
- 15.Medicare and Medicaid Programs; Electronic Health Record Incentive Program—Stage 3 and Modifications to Meaningful Use in 2015 Through 2017, 80 Fed. Reg 200 (October 16, 2015). Federal Register.Google Scholar
- 16.Hansten PD, Horn JR. Hansten and Horn Drug Interactions. 2016.Google Scholar
- 22.Horn JR, Hansten PD. Another thiopurine-allopurinol tragedy. Pharmacy Times; 2015.Google Scholar
- 23.Horn JR, Hansten PD. More evidence of a warfarin-antibiotic interaction. Pharmacy Times. 2009;75(6).Google Scholar
- 27.Methaneethorn J, Chaiwong K, Pongpanich K, Sonsingh P, Lohitnavy M. A pharmacokinetic drug-drug interaction model of simvastatin and clarithromycin in humans. Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference. 2014;2014:5703–6.Google Scholar
- 33.Peterson J. Integrating multiple medication decision support systems: how will we make it all work? AHRQ Perspectives on Safety: AHRQ; 2008.Google Scholar